study: ADMC_ADNI1 species: Human studyName: The Alzheimer's Disease Metabolomics Consortium Alzheimer�s Disease Neuroimaging Initiative 1 (ADMC_ADNI1) Study studyType: Individual consortium: AMP-AD dataTypeAll: Metabolomics, Clinical isModelSystem: false studyDescription: This study generated metabolomics data on the Alzheimer's Disease Neuroimaging Initiative (ADNI) multi-center longitudinal cohort study. The ADNI-1 cohort includes approximately 203 cognitively normal patients (CN), 358 patients diagnosed with late mild cognitive impairment (MCI), and 175 patients diagnosed with early probable AD. syn22024805